Lawrence DeGraaf, Head of Technology Business Development, GSK
Larry DeGraaf is the Head of Technology Business Development at GSK, based in Research Triangle Park, North Carolina. The Technology Business Development team at GSK is responsible for identifying and acquiring platform technologies and tools that enable drug development from target discovery through clinical development. Previously, Larry led the externalization and out-licensing group within GSK Business Development overseeing out-licensing, spin-outs, divestments, and alternative financing arrangements. Larry joined GSK in 2001 and has been working in Business Development since 2010. Prior joining business development, Larry worked in GSK’s legal department acting as internal counsel for business development transactions and the Infectious Diseases research unit. Prior to joining GSK Larry practiced law with a private firm. Larry received his JD from the University of Virginia, School of Law and a BA from Amherst College.
